Cargando…

Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model

Tuberculosis (TB) remains a global pandemic despite the use of Bacillus Calmette-Guérin (BCG) vaccine, partly because BCG fails to effectively control adult pulmonary TB. The introduction of novel boost vaccines such as the human Adenovirus 5-vectored AdHu5Ag85A could improve and prolong the protect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damjanovic, Daniela, Khera, Amandeep, Afkhami, Sam, Lai, Rocky, Zganiacz, Anna, Jeyanathan, Mangalakumari, Xing, Zhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476612/ https://www.ncbi.nlm.nih.gov/pubmed/26098423 http://dx.doi.org/10.1371/journal.pone.0131175

Ejemplares similares

AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates
por: Jeyanathan, Mangalakumari, et al.
Publicado: (2015)

Subcutaneous BCG vaccination protects against streptococcal pneumonia via regulating innate immune responses in the lung
por: Kang, Alisha, et al.
Publicado: (2023)

Expression and role of VLA-1 in resident memory CD8 T cell responses to respiratory mucosal viral-vectored immunization against tuberculosis
por: Haddadi, Siamak, et al.
Publicado: (2017)

Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
por: Jeyanathan, Vidthiya, et al.
Publicado: (2022)

Recombinant AhpC antigen from Mycobacterium bovis boosts BCG-primed immunity in mice
por: DÜZENLİ, Özgün Fırat, et al.
Publicado: (2021)

Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes
por: Jeyanathan, Vidthiya, et al.
Publicado: (2023)

Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments
por: Lai, Rocky, et al.
Publicado: (2015)

Continuous and Discontinuous Cigarette Smoke Exposure Differentially Affects Protective Th1 Immunity against Pulmonary Tuberculosis
por: Shaler, Christopher R., et al.
Publicado: (2013)

Mucosal-Pull Induction of Lung-Resident Memory CD8 T Cells in Parenteral TB Vaccine-Primed Hosts Requires Cognate Antigens and CD4 T Cells
por: Haddadi, Siamak, et al.
Publicado: (2019)

Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut–lung axis
por: Jeyanathan, Mangalakumari, et al.
Publicado: (2022)

Author Correction: Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut–lung axis
por: Jeyanathan, Mangalakumari, et al.
Publicado: (2023)

Comparative evaluation of booster efficacies of BCG, Ag85B, and Ag85B peptides based vaccines to boost BCG induced immunity in BALB/c mice: a pilot study
por: Husain, Aliabbas A., et al.
Publicado: (2015)

Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19
por: Afkhami, Sam, et al.
Publicado: (2023)

Vaccination with a BCG Strain Overexpressing Ag85B Protects Cattle against Mycobacterium bovis Challenge
por: Rizzi, Caroline, et al.
Publicado: (2012)

Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle
por: Dean, Gillian S., et al.
Publicado: (2015)

Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis
por: Chesson, Charles B., et al.
Publicado: (2018)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

The HyVac4 Subunit Vaccine Efficiently Boosts BCG-Primed Anti-Mycobacterial Protective Immunity
por: Billeskov, Rolf, et al.
Publicado: (2012)

Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against Mycobacterium kansasii
por: Komine-Aizawa, Shihoko, et al.
Publicado: (2021)

IL-12 DNA Displays Efficient Adjuvant Effects Improving Immunogenicity of Ag85A in DNA Prime/MVA Boost Immunizations
por: Morelli, María Paula, et al.
Publicado: (2020)

Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8(+) T Cells
por: Chapman, Rosamund, et al.
Publicado: (2012)

Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG
por: Taniguchi, Keiichi, et al.
Publicado: (2013)

Self-adjuvanting nanovaccines boost lung-resident CD4(+) T cell immune responses in BCG-primed mice
por: Files, Megan A., et al.
Publicado: (2022)

Mycobacterium bovis Osteitis Following Immunization with Bacille Calmette-Guérin (BCG) in Korea
por: Choi, Youn Young, et al.
Publicado: (2018)

Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine Babesiosis
por: Bastos, Reginaldo G., et al.
Publicado: (2022)

Immunogenicity and Protective Efficacy against Murine Tuberculosis of a Prime-Boost Regimen with BCG and a DNA Vaccine Expressing ESAT-6 and Ag85A Fusion Protein
por: Lu, Jia, et al.
Publicado: (2011)

Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice
por: Wu, Juan, et al.
Publicado: (2022)

Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection
por: Xu, Zheng Zhong, et al.
Publicado: (2016)

A Dendritic Cell-Activating Rv1876 Protein Elicits Mycobacterium Bovis BCG-Prime Effect via Th1-Immune Response
por: Choi, Seunga, et al.
Publicado: (2021)

Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c
por: Gunasena, Manuja, et al.
Publicado: (2022)

Assessment of immunological markers and booster effects of Ag85B peptides, Ag85B, and BCG in blood of BCG vaccinated children: a preliminary report
por: Husain, Aliabbas A., et al.
Publicado: (2016)

Immunological considerations for COVID-19 vaccine strategies
por: Jeyanathan, Mangalakumari, et al.
Publicado: (2020)

Rapid loss of early antigen-presenting activity of lymph node dendritic cells against Ag85A protein following Mycobacterium bovis BCG infection
por: Xu, Zhengzhong, et al.
Publicado: (2018)

COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
por: Singh, Ramandeep, et al.
Publicado: (2021)

Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials
por: Pathan, Ansar A., et al.
Publicado: (2007)

Curcumin Nanoparticles Enhance Mycobacterium bovis BCG Vaccine Efficacy by Modulating Host Immune Responses
por: Ahmad, Shaheer, et al.
Publicado: (2019)

Immunogenicity and Protective Efficacy of a Novel Recombinant BCG Strain Overexpressing Antigens Ag85A and Ag85B
por: Wang, Chun, et al.
Publicado: (2012)

A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4(+) and CD8(+) T-Cell Response against Mycobacterium tuberculosis Immunogens
por: Lu, Miao, et al.
Publicado: (2014)

Modulation of humoral immune response to oral BCG vaccination by Mycobacterium bovis BCG Moreau Rio de Janeiro (RDJ) in healthy adults
por: Monteiro-Maia, Renata, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_libvg76dao18i3f65oj1olikr3